Classical ADT to inhibit prostate tumor growth also affects tumor-associated T cells by influencing T cell-intrinsic AR signaling, preventing T cell exhaustion and overcoming immunotherapy resistance. The gene discussed is AR; the disease is prostate neoplasm.